Hot Topics in International Trade - Tariff Mitigation Strategies
Daily Compliance News: May 21, 2025, The I Want You Back Edition
Hot Topics in International Trade Terrified by Tariffs Braumiller Law
10 For 10: Top Compliance Stories For the Week Ending May 10, 2025
Daily Compliance News: May 6, 2025 the Made in China Edition
Daily Compliance News: May 5, 2025, The Washing Edition
Daily Compliance News: April 30, 2025, The 4 AM Wake-Up Call Edition
10 For 10: Top Compliance Stories For the Week Ending April 26, 2025
Daily Compliance News: April 25, 2025, The Trouble in Travel Edition
What's the Buzz in the Battery World With Roger Miksad, BCI – Battery + Storage Podcast
State AG Pulse | “Don’t Mess With Our Health or Our Kids!”
Daily Compliance News: April 21, 2025, The Tribute to Pope Francis Edition
Daily Compliance News: April 17, 2025, The Musk Fights BEE's Edition
Tit For Tat US China Trade War
Daily Compliance News: April 14, 2025, The Cascade of Corruption Edition
Sunday Book Review: April 13, 2025, The Books on Trade and Tariffs Edition
10 For 10: Top Compliance Stories For the Week Ending April 12, 2025
Daily Compliance News: April 11, 2025 The Tariff Rollback Edition
Daily Compliance News: April 10, 2025, The Dark Money Corruption Edition
Daily Compliance News: March 26, 2025, The Missile Strike on Boeing Edition
Welcome to 10 For 10, the podcast that brings you the week’s Top 10 compliance stories in one podcast each week. Tom Fox, the Voice of Compliance, brings you the compliance professional and the compliance stories you need to...more
On January 10, 2025, China's State Administration for Market Regulation ("SAMR"), the top anti-graft regulator, put into effect its first-of-its-kind Compliance Guidelines for Healthcare Companies to Prevent Commercial...more
Pending proposals to amend China's Anti-Unfair Competition Law (AUCL) may further blur the line between antitrust and anti-corruption offenses under China's enigmatic "counterparty bribery" rules. The AUCL, first enacted in...more
On January 14, 2025, China issued the final version of its compliance guidelines for health care companies to prevent commercial bribery risks (“Guidelines”), which took effect immediately. The Guidelines are applicable to...more
On January 10, 2025, China’s State Administration for Market Regulation (SAMR) officially released the Compliance Guidelines on Preventing Commercial Bribery Risks for Pharmaceutical Enterprises (the Guidelines). This...more
On January 14, 2025, China's State Administration for Market Regulation ("SAMR"), the primary regulatory agency in China for overseeing market supervision, issued its Compliance Guidelines for Health Care Companies to Prevent...more